Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by Garp1on Dec 20, 2016 9:34am
118 Views
Post# 25623715

RE:Just another drop off point for the impatient

RE:Just another drop off point for the impatientMy view

Share price pullback always affects morale. Doubt creeps in for all sorts of reasons, like:
  • Is something wrong in Taiwan?
  • Does TH think there is a problem?
  • Why does TH do a bought deal at this time?
  • Is the stock heading back to 2$?
  • Are we the bagholders?

As you can see, there is room for a lot of insinuations and scenarios but the facts for now remain the same:
  • This is a blockbuster drug.
  • It went through all the phases with flying colors up to now.
  • The established plan was well respected and is almost on target.
  • Luc remains constant with himself with is insecurity.
  • Good insider buying which was done in large part by one individual who knows the market.
Actually patience is not necessary, but avoiding to give away your share is. Let the shorters and Day traders hang themselves.


Bullboard Posts